Worrying about sales volumes for a product that hasn't even received TGA, FDA or any other regulatory approval seems a bit over the top to me. It's a positive that we can even make those sales as the feedback will help with the regulatory processes. We should be focusing on the potential sales volumes in the US and globally, not worrying about initial pre-approval sales volumes in a relatively very small market like Australia.
LTP Price at posting:
86.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)